GHK-Cu + BPC-157 + TB-500

GLOW is an advanced regenerative composite that maintains three independent peptide-delivery populations in a single research formulation: GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg).

BPC-157 and TB-500 are separately nano-encapsulated within lipid-based carriers. BPC-157 is engineered for delayed release to more closely align its exposure profile with the longer-duration release profile of TB-500. GHK-Cu is separately encapsulated within a depot-forming delivery system designed to provide gradual local release and reduce rapid local exposure. The three peptide populations remain separate within the formulation, preventing interaction and degradation in the liquid medium until the lipid carriers are processed in vivo.

GHK-Cu is a copper-binding tripeptide studied extensively for its role in stimulating collagen and elastin synthesis, accelerating wound closure, and modulating tissue inflammation. BPC-157, a synthetic pentadecapeptide derived from gastric juice, is researched for its profound angiogenic, cytoprotective, and tendon-healing properties, with studies showing accelerated recovery in ligament, muscle, and gastrointestinal tissue models. TB-500, the active fragment of Thymosin Beta-4, up-regulates actin polymerization and cell migration, promoting structural tissue repair and reducing fibrotic scar formation.

Together, these three peptides create a synergistic regenerative environment studied for soft-tissue repair, dermal rejuvenation, hair-follicle stimulation, and post-injury recovery acceleration. This blend is intended for researchers investigating tissue regeneration, inflammatory modulation, and wound-healing kinetics. For research purposes only.